LifeVantage (NASDAQ:LFVN) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVNGet Rating) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating on the stock.

LFVN stock opened at $4.89 on Thursday. The firm has a market capitalization of $61.57 million, a PE ratio of 6.99 and a beta of 1.39. LifeVantage has a twelve month low of $3.80 and a twelve month high of $8.63. The stock has a 50-day simple moving average of $4.27 and a two-hundred day simple moving average of $5.20.

LifeVantage (NASDAQ:LFVNGet Rating) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported $0.12 earnings per share (EPS) for the quarter. The firm had revenue of $50.00 million during the quarter. LifeVantage had a return on equity of 27.19% and a net margin of 4.49%. During the same quarter last year, the business posted $0.20 EPS. As a group, sell-side analysts expect that LifeVantage will post 0.54 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. lifted its position in LifeVantage by 39.0% in the 4th quarter. Victory Capital Management Inc. now owns 10,633 shares of the company’s stock worth $67,000 after buying an additional 2,983 shares during the last quarter. State Street Corp lifted its position in LifeVantage by 7.6% in the first quarter. State Street Corp now owns 46,191 shares of the company’s stock valued at $220,000 after purchasing an additional 3,281 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its position in LifeVantage by 49.8% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company’s stock valued at $148,000 after purchasing an additional 7,804 shares during the last quarter. American Century Companies Inc. lifted its position in LifeVantage by 38.7% in the fourth quarter. American Century Companies Inc. now owns 35,310 shares of the company’s stock valued at $223,000 after purchasing an additional 9,856 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in LifeVantage in the fourth quarter valued at approximately $63,000. Institutional investors own 29.54% of the company’s stock.

About LifeVantage (Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Further Reading

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.